Home › Companies › AXSOME THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and AXSOME THERAPEUTICS INC.’s Form 8-K, filed 2024-06-11 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AXSOME THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AXSOME THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Herriot Tabuteau, M.D. | 33,257,792 | -- | -- | 526,545 | 6,137,450 | Majority: yes |
| Elect Director: Mark Coleman, M.D. | 27,121,859 | -- | -- | 6,662,478 | 6,137,450 | Majority: yes |
| Proposal 2: Ratification of Appointment of Deloitte & Touche LLP | 39,146,384 | 153,117 | 622,286 | -- | 0 | Majority: yes |
| Proposal 3: Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's Named Executive Officers | 32,850,943 | 866,046 | 67,348 | -- | 6,137,450 | Majority: yes |
Source: AXSOME THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-11 — read the filing on EDGAR.
Each item below shows how the 264 asset managers that disclosed a AXSOME THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 13 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
AXSOME THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's Named Executive Officers”): 32,850,943 for, 866,046 against, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,464,575 outstanding shares: 69% for, 2% against (71% of the company cast a for/against vote).
The 261 asset managers below cast 98% of the shares they voted on this item FOR (23,901,016 for, 490,611 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,458,909 | 0 | 0 | 0 | For |
| Fairmount Funds Management LLC | 2,360,077 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 2,269,618 | 0 | 0 | 0 | For |
| BlackRock | 1,179,168 | 4,074 | 0 | 0 | For |
| Putnam | 1,143,550 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,000,000 | 0 | 0 | 0 | For |
| Invesco | 793,323 | 205,418 | 0 | 0 | For |
| State Street | 917,333 | 248 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 795,372 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 770,436 | 0 | 0 | 0 | For |
| Charles Schwab | 605,699 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 471,954 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| Wellington | 447,039 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| Loomis Sayles | 402,805 | 0 | 0 | 0 | For |
| Fidelity | 402,433 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 394,995 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 365,775 | 0 | 0 | 0 | For |
| JPMorgan | 301,273 | 0 | 0 | 0 | For |
| Point72 | 297,338 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 254,535 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 215,097 | 0 | 0 | 0 | For |
| Northern Trust | 208,820 | 25 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
Showing the 25 largest of 261 asset managers. See all 261 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
AXSOME THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herriot Tabuteau, M.D.”): 33,257,792 for, 526,545 withheld, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,464,575 outstanding shares: 70% for, 1% withheld (71% of the company cast a for/withheld vote).
The 79 asset managers below cast 100% of the shares they voted on this item FOR (7,418,176 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 484,796 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 302,849 | 0 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
| Loomis Sayles | 160,400 | 0 | 0 | 0 | For |
| State Street | 135,929 | 0 | 98 | 0 | For |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 65,263 | 0 | 0 | 0 | For |
| First Trust | 52,484 | 0 | 0 | 0 | For |
| Equitable | 49,433 | 0 | 0 | 0 | For |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 43,602 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 43,297 | 0 | 0 | 0 | For |
| Allspring | 41,059 | 0 | 0 | 0 | For |
| MoA Funds Corp | 41,005 | 0 | 0 | 0 | For |
| Lincoln Financial | 40,227 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
AXSOME THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mark Coleman, M.D.”): 27,121,859 for, 6,662,478 withheld, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,464,575 outstanding shares: 57% for, 14% withheld (71% of the company cast a for/withheld vote).
The 79 asset managers below cast 99.9% of the shares they voted on this item FOR (4,998,217 for, 67 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 484,796 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 466,323 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 414,486 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 302,849 | 0 | Abstain |
| Waddell & Reed | 0 | 0 | 199,260 | 0 | Abstain |
| Loomis Sayles | 0 | 0 | 160,400 | 0 | Abstain |
| State Street | 289 | 0 | 135,738 | 0 | Abstain |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 65,263 | 0 | Abstain |
| First Trust | 0 | 0 | 52,484 | 0 | Abstain |
| Equitable | 9,353 | 0 | 40,080 | 0 | Abstain |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 43,602 | 0 | Abstain |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 43,297 | 0 | Abstain |
| Allspring | 0 | 0 | 41,059 | 0 | Abstain |
| MoA Funds Corp | 0 | 0 | 41,005 | 0 | Abstain |
| Lincoln Financial | 10,527 | 0 | 29,700 | 0 | Abstain |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
AXSOME THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Ratification of Appointment of Deloitte & Touche LLP”): 39,146,384 for, 153,117 against, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,464,575 outstanding shares: 82% for, 0.4% against (83% of the company cast a for/against vote).
The 79 asset managers below cast 99.8% of the shares they voted on this item FOR (7,422,505 for, 12,523 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 484,796 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 302,849 | 0 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
| Loomis Sayles | 160,400 | 0 | 0 | 0 | For |
| State Street | 136,027 | 0 | 0 | 0 | For |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 65,263 | 0 | 0 | 0 | For |
| First Trust | 52,484 | 0 | 0 | 0 | For |
| Equitable | 49,433 | 0 | 0 | 0 | For |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 43,602 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 43,297 | 0 | 0 | 0 | For |
| Allspring | 41,059 | 0 | 0 | 0 | For |
| MoA Funds Corp | 41,005 | 0 | 0 | 0 | For |
| Lincoln Financial | 40,227 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Ranked by the number of AXSOME THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 47,464,575 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.29% |
| 2 | Fairmount Funds Management LLC | 4.97% |
| 3 | RTW INVESTMENTS, LP | 4.78% |
| 4 | BlackRock | 2.49% |
| 5 | Putnam | 2.41% |
| 6 | RA CAPITAL MANAGEMENT, L.P. | 2.11% |
| 7 | Invesco | 2.10% |
| 8 | State Street | 1.93% |
| 9 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1.68% |
| 10 | Deep Track Capital, LP | 1.62% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Herriot Tabuteau, M.D. | 19.31% | DEF14A |
| Antecip Capital LLC | 15.47% | DEF14A |
| RTW Investments, LP | 9.46% | DEF14A |
| Vanguard Group | 8.81% | 13F |
| BlackRock | 7.99% | 13F |
| Citadel Advisors | 2.74% | 13F |
| State Street | 1.98% | 13F |
| FMR (Fidelity) | 1.95% | 13F |
| Geode Capital | 1.78% | 13F |
| Millennium Management | 1.59% | 13F |
Percentages above are of 47,464,575 shares outstanding, as reported by AXSOME THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AXSOME THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AXSOME THERAPEUTICS INC.'s shareholder meeting held 2024-06-07, in the 2023-2024 proxy season, 264 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,156 separate fund positions. On the most widely held item on that ballot — To approve, by non-binding advisory vote, the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AXSOME THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-11.
AXSOME THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.